Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000131

President and CEO sold 2,692 shares at $1.66 ($4,470)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2022-09-28 Sale −2,692 $1.66 $4,470 537,867 D
Open-market sales · 2,692 sh · avg $1.66 · $4,470
Loading xslF345X03/wf-form4_166458101110775.xml…